EHC - Company ID 0000785161
The table below shows Encompass Health Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.59B | $1.48B | $1.46B | $1.46B | $1.35B | $1.30B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Encompass Health Corp reported annual revenue of $5.94B for fiscal year 2025. That is up 10.5% from $5.37B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $3.64B (FY 2016) to $5.94B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $58.20M |
| $56.10M |
| $59.40M |
| $52.30M |
| $54.00M |
| $50.50M |
| Operating income | - | - | - | - | - | - |
| Income tax | $56.40M | $44.90M | $51.00M | $41.60M | $36.00M | $38.30M |
| Net income | $194.50M | $126.50M | $142.10M | $151.50M | $108.20M | $114.10M |
| EPS (diluted) | $1.93 | $1.24 | $1.39 | $1.48 | $1.06 | $1.12 |